Literature DB >> 14978668

Development of quality of care indicators for Parkinson's disease.

Eric M Cheng1, Andrew Siderowf, Kari Swarztrauber, Mahmood Eisa, Martin Lee, Barbara G Vickrey.   

Abstract

Parkinson's disease (PD) is a major cause of disability. To date, there have been no large-scale efforts to measure the quality of PD care because of a lack of quality indicators for conducting an explicit review of PD care processes. We present a set of quality indicators for PD care. Based on a structured review of the medical literature, 79 potential indicators were drafted. Through a two-round modified Delphi process, an expert panel of seven movement disorders specialists rated each indicator on criteria of validity, feasibility, impact on outcomes, room for improvement, and overall utility. Seventy-one quality indicators met validity and feasibility thresholds. Applying thresholds for impact on outcomes, room for improvement, and overall utility, a subset of 29 indicators was identified, spanning dopaminergic therapy, assessment of functional status, assessment and treatment of depression, coordination of care, and medication use. Multivariable analysis showed that overall utility ratings were driven by validity and impact on outcomes (P < 0.01). An expert panel can reach consensus on a set of highly rated quality indicators for PD care, which can be used to assess quality of PD care and guide the design of quality improvement projects.

Entities:  

Mesh:

Year:  2004        PMID: 14978668     DOI: 10.1002/mds.10664

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  Evidence from clinical trials: can we do better?

Authors:  Andrew D Siderowf
Journal:  NeuroRx       Date:  2004-07

2.  Emerging subspecialties in neurology: health services research.

Authors:  Nabila Dahodwala; Ana-Claire Meyer
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

3.  Validity versus feasibility for quality of care indicators: expert panel results from the MI-Plus study.

Authors:  Adolfo Peña; Sandeep S Virk; Richard M Shewchuk; Jeroan J Allison; O Dale Williams; Catarina I Kiefe
Journal:  Int J Qual Health Care       Date:  2010-04-09       Impact factor: 2.038

4.  Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.

Authors:  Inger van Steenoven; Dag Aarsland; Howard Hurtig; Alice Chen-Plotkin; John E Duda; Jacqueline Rick; Lama M Chahine; Nabila Dahodwala; John Q Trojanowski; David R Roalf; Paul J Moberg; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-11-07       Impact factor: 10.338

5.  Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Authors:  E M Cheng; S Tonn; R Swain-Eng; S A Factor; W J Weiner; C T Bever
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

6.  Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization.

Authors:  Peijun Chen; Helen C Kales; Daniel Weintraub; Frederic C Blow; Lan Jiang; Rosalinda V Ignacio; Alan M Mellow
Journal:  Int J Geriatr Psychiatry       Date:  2007-06       Impact factor: 3.485

7.  Randomized trial of care management to improve Parkinson disease care quality.

Authors:  Karen I Connor; Eric M Cheng; Frances Barry; Hilary C Siebens; Martin L Lee; David A Ganz; Brian S Mittman; Megan K Connor; Lisa K Edwards; Michael G McGowan; Barbara G Vickrey
Journal:  Neurology       Date:  2019-03-22       Impact factor: 9.910

8.  Quality indicators for multiple sclerosis.

Authors:  Eric M Cheng; Carolyn J Crandall; Christopher T Bever; Barbara Giesser; Jodie K Haselkorn; Ron D Hays; Paul Shekelle; Barbara G Vickrey
Journal:  Mult Scler       Date:  2010-06-18       Impact factor: 6.312

9.  The quality of care delivered to Parkinson's disease patients in the U.S. Pacific Northwest Veterans Health System.

Authors:  Kari Swarztrauber; Eric Graf; Eric Cheng
Journal:  BMC Neurol       Date:  2006-07-28       Impact factor: 2.474

10.  Study protocol of "CHAPS": a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson's Disease to improve the quality of care for individuals with Parkinson's disease.

Authors:  Karen Connor; Eric Cheng; Hilary C Siebens; Martin L Lee; Brian S Mittman; David A Ganz; Barbara Vickrey
Journal:  BMC Neurol       Date:  2015-12-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.